当前位置:首页 - 行情中心 - 久吾高科(300631) - 财务分析 - 利润表

久吾高科

(300631)

  

流通市值:42.02亿  总市值:43.57亿
流通股本:1.21亿   总股本:1.25亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入270,447,031.9286,434,031.64533,286,878.2300,613,690.12
  营业收入270,447,031.9286,434,031.64533,286,878.2300,613,690.12
二、营业总成本221,982,037.8177,885,892.63491,493,814.36314,896,462.65
  营业成本138,703,827.2940,839,427.11314,853,563.91194,595,356.92
  税金及附加4,721,627.581,661,482.425,821,359.214,420,915.11
  销售费用25,961,158.79,017,412.0454,740,726.3534,605,481.72
  管理费用28,403,089.1314,277,066.6460,861,415.8743,464,922.57
  研发费用22,067,32510,967,549.0956,228,737.7337,392,072.5
  财务费用2,125,010.111,122,955.33-1,011,988.71417,713.83
  其中:利息费用1,130,231.83513,819.932,177,009.031,550,620.4
  其中:利息收入804,108.15437,833.862,113,081.551,659,992.15
三、其他经营收益
  加:公允价值变动收益2,585,245.861,928,473.4-212,141.011,151,331.49
  加:投资收益8,372,600.593,559,966.3524,116,046.8214,727,587.38
  资产处置收益68,544.55-501.99119,829.93148,997.01
  资产减值损失(新)-1,786,820.27-422,098.52-10,723,088.69132,968.4
  信用减值损失(新)-30,509,763.6-412,223.4-17,289,155.539,513,559.91
  其他收益11,603,852.574,894,671.459,765,204.825,849,977.61
四、营业利润38,798,653.8118,096,426.347,569,760.1817,241,649.27
  加:营业外收入52,706.312,001.13481,845.6891,412.2
  减:营业外支出945,946.6210,200.06487,122.68441,603.01
五、利润总额37,905,413.518,088,227.3747,564,483.1816,891,458.46
  减:所得税费用-783,413.24425,929.33-5,465,368.77-3,434,405.65
六、净利润38,688,826.7417,662,298.0453,029,851.9520,325,864.11
(一)按经营持续性分类
  持续经营净利润38,688,826.7417,662,298.0453,029,851.9520,325,864.11
  终止经营净利润-0--
(二)按所有权归属分类
  归属于母公司股东的净利润38,693,289.517,664,537.6753,015,388.0720,299,748.99
  少数股东损益-4,462.76-2,239.6314,463.8826,115.12
  扣除非经常损益后的净利润28,852,685.7612,370,292.5247,192,676.0916,026,335.74
七、每股收益
  (一)基本每股收益0.320.150.430.16
  (二)稀释每股收益0.320.150.430.16
九、综合收益总额38,688,826.7417,662,298.0453,029,851.9520,325,864.11
  归属于母公司股东的综合收益总额38,693,289.517,664,537.6753,015,388.0720,299,748.99
  归属于少数股东的综合收益总额-4,462.76-2,239.6314,463.8826,115.12
公告日期2025-08-192025-04-222025-04-222024-10-22
审计意见(境内)标准无保留意见
TOP↑